GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vaishali Pharma Ltd (NSE:VAISHALI) » Definitions » EV-to-Revenue

Vaishali Pharma (NSE:VAISHALI) EV-to-Revenue : 2.05 (As of Jun. 08, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Vaishali Pharma EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Vaishali Pharma's enterprise value is ₹1,520.5 Mil. Vaishali Pharma's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₹742.8 Mil. Therefore, Vaishali Pharma's EV-to-Revenue for today is 2.05.

The historical rank and industry rank for Vaishali Pharma's EV-to-Revenue or its related term are showing as below:

NSE:VAISHALI' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.56   Med: 1.64   Max: 3.57
Current: 2.05

During the past 11 years, the highest EV-to-Revenue of Vaishali Pharma was 3.57. The lowest was 0.56. And the median was 1.64.

NSE:VAISHALI's EV-to-Revenue is ranked better than
54.12% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 2.275 vs NSE:VAISHALI: 2.05

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-08), Vaishali Pharma's stock price is ₹141.30. Vaishali Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹63.73. Therefore, Vaishali Pharma's PS Ratio for today is 2.22.


Vaishali Pharma EV-to-Revenue Historical Data

The historical data trend for Vaishali Pharma's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaishali Pharma EV-to-Revenue Chart

Vaishali Pharma Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.63 1.01 0.99 1.25 2.63

Vaishali Pharma Quarterly Data
Sep18 Mar19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.25 2.63 1.97 2.06 2.74

Competitive Comparison of Vaishali Pharma's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Vaishali Pharma's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vaishali Pharma's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vaishali Pharma's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Vaishali Pharma's EV-to-Revenue falls into.



Vaishali Pharma EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Vaishali Pharma's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1520.473/742.831
=2.05

Vaishali Pharma's current Enterprise Value is ₹1,520.5 Mil.
Vaishali Pharma's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹742.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vaishali Pharma  (NSE:VAISHALI) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Vaishali Pharma's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=141.30/63.728
=2.22

Vaishali Pharma's share price for today is ₹141.30.
Vaishali Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹63.73.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vaishali Pharma EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Vaishali Pharma's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Vaishali Pharma (NSE:VAISHALI) Business Description

Traded in Other Exchanges
N/A
Address
R.C. Patel Road, Off Sodawala Lane, 706-709, 7th Floor, Aravalli Business Center, Borivili (West), Mumbai, MH, IND, 400092
Vaishali Pharma Ltd is a pharmaceutical company. The company is engaged in the business of trading (including exports) pharmaceuticals products. It mainly deals in Active Pharmaceutical Ingredient, pharmaceutical formulations, surgical products, Herbal and Nutraceutical Products, and veterinary supplements operating in the domestic and export market.

Vaishali Pharma (NSE:VAISHALI) Headlines

No Headlines